Skip to main content
Transcenta Holding Limited logo

Transcenta Holding Limited — Investor Relations & Filings

Ticker · 6628 ISIN · KYG9005B1041 HKEX Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2022-11-04 Declaration of Voting R…
Country HK Hong Kong
Listing HKEX 6628

About Transcenta Holding Limited

http://www.transcenta.com

Transcenta Holding Limited is a clinical-stage global biotherapeutics company specializing in the discovery, research, development, and manufacturing of differentiated antibody-based therapeutics. The company operates a fully integrated platform, utilizing a unique antibody generation platform based on Immune Tolerance Breaking Technology to generate candidate leads. Its robust pipeline includes therapeutic antibody molecules targeting oncology and selected non-oncology indications, such as bone and kidney disorders. The company employs advanced bioprocessing technologies, including perfusion-based continuous bioprocessing, to accelerate process development and reduce manufacturing costs.

Recent filings

Filing Released Lang Actions
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON FRIDAY, 4 NOVEMBER 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from an Extraordinary General Meeting (EGM) held on 4 November 2022. It details the voting outcomes on specific resolutions related to the Share Incentive Scheme. The text references the EGM notice and circular but does not contain full meeting materials or presentations. It is a formal announcement of voting results rather than the meeting materials themselves or a detailed report. The document length is about 4960 characters, which is consistent with a typical voting results announcement. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-11-04 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed tables of repurchases of shares on various dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong (SEHK). The document is a regulatory disclosure about share repurchases and changes in issued share capital, not a financial report or earnings release. It is a formal notification of transactions in the company's own shares (share buybacks). Therefore, the document fits the category of 'Transaction in Own Shares' (POS). The document length is sufficient and contains detailed transactional data, confirming it is not merely an announcement or certification but a substantive report of share repurchase activity.
2022-11-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly report on movements in securities, specifically focusing on share capital, issued shares, share options, repurchases, and confirmations related to securities issued by Transcenta Holding Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules, particularly Chapter 19B. The document includes detailed tables of share capital changes, share options exercised, repurchases, and confirmations by an executive director. It is not a full annual or quarterly financial report, nor is it an earnings release or management discussion. It is a regulatory filing providing detailed monthly updates on share capital and securities movements, which aligns with the category of Regulatory Filings (RNS) as a general regulatory announcement and compliance document. The document length is over 10,000 characters and contains substantive data, but it is not a financial report per se, nor an announcement of a report publication. Therefore, the best classification is Regulatory Filings (RNS).
2022-11-04 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It details numerous repurchases of shares over various dates, confirming compliance with listing rules and providing specifics on share repurchase transactions. The document is a regulatory disclosure about share repurchases, not a financial report or earnings release. It fits the description of a report on the company buying back its own shares. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a high confidence in this classification.
2022-11-03 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed tables of repurchases of shares on various dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content focuses on share repurchase transactions and confirmations related to these transactions. There are no financial statements, earnings data, or management discussion. The document is a regulatory disclosure about share repurchases and capital changes, fitting the category of Transaction in Own Shares (POS). The document length is over 13,000 characters and contains detailed transactional data, not just an announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA).
2022-11-02 English
(Revised) Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed tables of repurchases of shares on various dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The document is a regulatory disclosure about share repurchases and changes in issued shares, not a financial report or earnings release. It is a formal regulatory filing required by the exchange to disclose capital changes and share buybacks. Therefore, it fits best under the category 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2022-11-02 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.